Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Barclays Downgrades Sunrun to Equal-Weight, Lowers Price Target to $35

Barclays analyst Christine Cho downgrades Sunrun (NASDAQ:RUN) from Overweight to Equal-Weight and lowers the price target from $44 to $35.

byBenzinga Newsdesk

January 25, 2023

1 minute read

Barclays analyst Christine Cho downgrades Sunrun (NASDAQ:RUN) from Overweight to Equal-Weight and lowers the price target from $44 to $35.

RBC Capital Maintains Sector Perform on Sage Therapeutics, Lowers Price Target to $48

By Benzinga Newsdesk

Today, 2:12 AM

RBC Capital analyst Brian Abrahams maintains Sage Therapeutics (NASDAQ:SAGE) with a Sector Perform and lowers the price target from $52 to $48.

SAGE

North Korea Conducted Missile Test On Tuesday

By Michael Horton

Today, 2:12 AM

-Reuters

EWY

Credit Suisse Outlines Details On $4B Capital Raise Plan

By Vandana Singh

Today, 2:12 AM

Credit Suisse Group AG (NYSE: CS) has enlarged the banking syndicate underwriting the rights issue and announced the reference price for the proposed CHF4 billion capital raise.

Raymond James Maintains Market Perform on Silvercorp Metals, Lowers Price Target to C$6.5

By Benzinga Newsdesk

Today, 2:12 AM

Raymond James maintains Silvercorp Metals (TSX:SVM) with a Market Perform and lowers the price target from C$7 to C$6.5.

TSX:SVM

Barclays Downgrades Sunrun to Equal-Weight, Lowers Price Target to $35

Related Posts

RBC Capital Maintains Sector Perform on Sage Therapeutics, Lowers Price Target to $48

North Korea Conducted Missile Test On Tuesday

Credit Suisse Outlines Details On $4B Capital Raise Plan

Raymond James Maintains Market Perform on Silvercorp Metals, Lowers Price Target to C$6.5